127 related articles for article (PubMed ID: 25692135)
1. In vitro bactericidal activity of 4- and 5-chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA.
Zadrazilova I; Pospisilova S; Pauk K; Imramovsky A; Vinsova J; Cizek A; Jampilek J
Biomed Res Int; 2015; 2015():349534. PubMed ID: 25692135
[TBL] [Abstract][Full Text] [Related]
2. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
Ozden S; Karataş H; Yildiz S; Göker H
Arch Pharm (Weinheim); 2004 Oct; 337(10):556-62. PubMed ID: 15476288
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the anti-Staphylococcus aureus fraction from Penthorum chinense Pursh stems.
Ding B; Ding Q; Zhang S; Jin Z; Wang Z; Li S; Dou X
BMC Complement Altern Med; 2019 Aug; 19(1):219. PubMed ID: 31419969
[TBL] [Abstract][Full Text] [Related]
5. Study of Biological Activities and ADMET-Related Properties of Salicylanilide-Based Peptidomimetics.
Pindjakova D; Pilarova E; Pauk K; Michnova H; Hosek J; Magar P; Cizek A; Imramovsky A; Jampilek J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232947
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-staphylococcal and anti-biofilm properties of two anti-malarial compounds: MMV665953 {1-(3-chloro-4-fluorophenyl)-3-(3,4-dichlorophenyl)urea} and MMV665807 {5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide}.
Zapotoczna M; Boksmati N; Donohue S; Bahtiar B; Boland A; Somali HA; Cox A; Humphreys H; O'Gara JP; Brennan M; O'Neill E
J Med Microbiol; 2017 Mar; 66(3):377-387. PubMed ID: 28327271
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
Arhin FF; Sarmiento I; Moeck G
Int J Antimicrob Agents; 2014 Jul; 44(1):65-8. PubMed ID: 24906505
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; das S; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2019 Mar; 83():569-579. PubMed ID: 30471579
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L
Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
Ertan T; Yildiz I; Ozkan S; Temiz-Arpaci O; Kaynak F; Yalcin I; Aki-Sener E; Abbasoglu U
Bioorg Med Chem; 2007 Mar; 15(5):2032-44. PubMed ID: 17223562
[TBL] [Abstract][Full Text] [Related]
12. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
Hardej D; Ashby CR; Khadtare NS; Kulkarni SS; Singh S; Talele TT
Eur J Med Chem; 2010 Dec; 45(12):5827-32. PubMed ID: 20947220
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
Patel BA; Ashby CR; Hardej D; Talele TT
Bioorg Med Chem Lett; 2013 Oct; 23(20):5523-7. PubMed ID: 24012180
[TBL] [Abstract][Full Text] [Related]
15. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
[TBL] [Abstract][Full Text] [Related]
16. In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin.
Vidaillac C; Parra-Ruiz J; Rybak MJ
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):470-3. PubMed ID: 22018937
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects between silibinin and antibiotics on methicillin-resistant Staphylococcus aureus isolated from clinical specimens.
Kang HK; Kim HY; Cha JD
Biotechnol J; 2011 Nov; 6(11):1397-408. PubMed ID: 21491604
[TBL] [Abstract][Full Text] [Related]
18. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.
Tsuji BT; Yang JC; Forrest A; Kelchlin PA; Smith PF
J Antimicrob Chemother; 2008 Jul; 62(1):156-60. PubMed ID: 18400804
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimicrobial activity of some novel 2-[4-(substituted piperazin-/piperidin-1-ylcarbonyl)phenyl]-1H-benzimidazole derivatives.
Kus C; Sözüdönmez F; Altanlar N
Arch Pharm (Weinheim); 2009 Jan; 342(1):54-60. PubMed ID: 19051196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
